Overview
A prescription form of tetrahydrocannabinol (THC) was investigated for its effect on trauma-related nightmares in individuals diagnosed with Post-Traumatic Stress Disorder (PTSD). The study indicated that more than one-third of participating patients experienced a complete cessation of these nightmares after a ten-week treatment period. This finding suggests a potential avenue for addressing a persistent and distressing symptom associated with PTSD.
Findings
- A prescription form of THC was utilized in the study.
- The THC medication was observed to assist individuals suffering from PTSD in mitigating recurring trauma-related nightmares.
- Over 33% (more than one-third) of the patients involved in the study reported that their nightmares completely disappeared.
- This complete disappearance of nightmares was noted after a treatment duration of ten weeks.
Why This Matters
The observed efficacy of a prescription THC medication in eliminating trauma-related nightmares for a significant portion of PTSD patients points towards a potential treatment for one of the disorder's most distressing and stubborn symptoms. This could represent a long-awaited therapeutic option for individuals seeking relief from this specific manifestation of PTSD.